Condition
Chronic Diabetic Foot Ulcer
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05338463Phase 4CompletedPrimary
Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients
NCT04838600Terminated
A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv®
NCT05849701Not ApplicableCompletedPrimary
Shock Wave Versus Vacuum Assisted Closure on Chronic Diabetic Foot Ulcer
NCT00709514Phase 2CompletedPrimary
Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
Showing all 4 trials